Please login to the form below

Not currently logged in
Email:
Password:

FibroGen

This page shows the latest FibroGen news and features for those working in and with pharma, biotech and healthcare.

FDA advisory committee votes against approval of AZ, FibroGen's roxadustat

FDA advisory committee votes against approval of AZ, FibroGen's roxadustat

The committee members concluded that AZ and FibroGen should produce additional safety data for roxadustat in this indication prior to marketing of the drug. ... Although we are disappointed by today’s outcome, we will continue to work closely with our

Latest news

More from news
Approximately 4 fully matching, plus 15 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • New hires at FibroGen, Saniona and Turbine New hires at FibroGen, Saniona and Turbine

    The latest movers in pharma. FibroGen . FibroGen has appointed Enrique Conterno (pictured below, left) as its chief executive officer, after he recently retired from his role as senior vice president for ... This is a tremendously exciting time for

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...